Zhu, X. Comment on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: A real-world, retrospective bicenter cohort study’. BMJ Publishing Group.
Chicago Style (17th ed.) CitationZhu, Xudong. Comment on ‘Pembrolizumab Hybrid Dosing Is Non-inferior to Flat Dosing in Advanced Non-small Cell Lung Cancer: A Real-world, Retrospective Bicenter Cohort Study’. BMJ Publishing Group.
MLA (9th ed.) CitationZhu, Xudong. Comment on ‘Pembrolizumab Hybrid Dosing Is Non-inferior to Flat Dosing in Advanced Non-small Cell Lung Cancer: A Real-world, Retrospective Bicenter Cohort Study’. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.